Rapid detection of

Bone metastases Decalcification EGFR mutation Lung carcinoma Tyrosine kinase inhibitor

Journal

Journal of bone oncology
ISSN: 2212-1366
Titre abrégé: J Bone Oncol
Pays: Netherlands
ID NLM: 101610292

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 18 12 2019
revised: 09 01 2020
accepted: 09 01 2020
entrez: 21 1 2020
pubmed: 21 1 2020
medline: 21 1 2020
Statut: epublish

Résumé

Detection of molecular alterations in lung cancer bone metastasis (LCBM) is particularly difficult when decalcification procedure is needed. The Idylla™ real-time (RT)-PCR is compared to the routine method used in our laboratory, which combines next generation and Sanger sequencing, for the detection of

Identifiants

pubmed: 31956476
doi: 10.1016/j.jbo.2020.100277
pii: S2212-1374(19)30251-9
pii: 100277
pmc: PMC6962695
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100277

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

MB received grants from Biocartis, Astra Zeneca, BMS, and Pfizer to conduct research on lung cancer.

Références

J Clin Pathol. 2018 Aug;71(8):745-750
pubmed: 29798838
Am J Clin Pathol. 2016 Feb;145(2):222-37
pubmed: 27124905
J Mol Diagn. 2019 Sep;21(5):862-872
pubmed: 31443844
Onco Targets Ther. 2018 Apr 23;11:2303-2309
pubmed: 29731638
J Clin Oncol. 2017 Oct 20;35(30):3484-3515
pubmed: 28806116
Virchows Arch. 2019 Dec;475(6):693-699
pubmed: 31267202
J Histochem Cytochem. 1999 May;47(5):703-10
pubmed: 10219063
J Thorac Oncol. 2016 Oct;11(10):1798-801
pubmed: 27211795
J Mol Diagn. 2019 Nov;21(6):1010-1024
pubmed: 31445213
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
J Clin Pathol. 2017 Jun;70(6):544-549
pubmed: 28153953
Ann Oncol. 2017 Nov 1;28(11):2715-2724
pubmed: 28945865
J Clin Pathol. 2018 Sep;71(9):757-762
pubmed: 29903742
J Thorac Oncol. 2011 Mar;6(3):576-82
pubmed: 21270669
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s
pubmed: 17062708
J Clin Pathol. 2020 Jan;73(1):35-41
pubmed: 31296605

Auteurs

Antoine Boureille (A)

Hospices Civils de Lyon, Institut de pathologie multisite, Site Est, Bron, France.
Univ Lyon, Université Claude Bernard Lyon 1, France.

Carole Ferraro-Peyret (C)

Hospices Civils de Lyon, Institut de pathologie multisite, Site Est, Bron, France.
Univ Lyon, Université Claude Bernard Lyon 1, France.

Guillaume Pontarollo (G)

Hospices Civils de Lyon, Institut de pathologie multisite, Site Est, Bron, France.
Univ Lyon, Université Claude Bernard Lyon 1, France.

Cyrille Confavreux (C)

Univ Lyon, Université Claude Bernard Lyon 1, France.
Hospices Civils de Lyon, Service de rhumatologie, Pierre-Bénite, France.

Jean-Baptiste Pialat (JB)

Univ Lyon, Université Claude Bernard Lyon 1, France.
Hospices Civils de Lyon, Service de radiologie, Pierre-Bénite, France.

Sylvie Isaac (S)

Univ Lyon, Université Claude Bernard Lyon 1, France.
Hospices Civils de Lyon, Institut de pathologie multisite, Site Sud, Pierre-Bénite, France.

Fabien Forest (F)

Service de pathologie, Centre hospitalier universitaire de Saint Etienne - Hôpital Nord, Saint Etienne, France.

Violaine Yvorel (V)

Service de pathologie, Centre hospitalier universitaire de Saint Etienne - Hôpital Nord, Saint Etienne, France.

Emmanuel Watkin (E)

Cabinet de pathologie CYPATH, Villeurbanne, France.

Nicolas Girard (N)

Univ Lyon, Université Claude Bernard Lyon 1, France.
Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.

Marie Brevet (M)

Hospices Civils de Lyon, Institut de pathologie multisite, Site Est, Bron, France.
Univ Lyon, Université Claude Bernard Lyon 1, France.

Classifications MeSH